Where does Immunolight, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immunolight, LLC ranks #3,735 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immunolight, LLC hold?

Immunolight, LLC holds 97 US utility patents granted between 2015 and 2025, spanning 52 technology areas.

What is Immunolight, LLC's Innovation Score?

Immunolight, LLC has an Innovation Score of 61.3 out of 100 (top 3% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Immunolight, LLC's patent grant rate increasing or decreasing?

Immunolight, LLC's recent grant velocity is -8% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Immunolight, LLC's patents?

Immunolight, LLC's patents average 51.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immunolight, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Immunolight, LLC

Q: What technology areas does Immunolight, LLC focus on?

Immunolight, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 72 patents. Grants appear in 52 CPC subclasses total.

USPTO PatentsView assignee record - 97 granted patents across 52 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immunolight ranks #3,735 of 49,997 tracked US assignees by granted-patent volume, with 97 patents across 52 technology areas.

#3,735
of 49,997 US assignees by volume: Top 3%
by Innovation Score (61.3/100): 51.1
avg claims per patent: -8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3735 · US Corporation #3,735 · 97 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 97 grants
TOP-DECILE #3,735/49,997
PHOTO-FINISH DSP Group
CPC-WIDE A61N · 52 areas
INNOV-STRONG 61.3/100
CLAIMS-DENSE 51.1 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -8% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: DSP Group Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bendix Commercial… · near

61
IX Innovation · near

61
PlayNitride Display · near

61
Globalwafers · near

61
Immunolight · this assignee

61
3D Lighting… · lowest

7

What this shows Immunolight's Innovation Score is 61.3/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Immunolight's grant cadence moved

Between 2020–2024, Immunolight, LLC received 46 grants versus 50 in 2015–2019 (-8% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2019 at 14 grants and bottomed in 2015 at 6. Lead class A61N accounts for 74.2% of the portfolio across 52 subclasses. Volume neighbours: DSP Group Ltd. (#3,730) and Mobile Technology Corporation (#3,738).

Immunolight's three-year grant acceleration

From 2019–2021 to 2022–2024, Immunolight, LLC moved from 33 to 27 grants (0.82x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

DSP Group

97
Dynasty Footwear

97
Eppendorf

97
Harbor Freight To…

97
Koninklijke Phili…

97
Korea Institute o…

97
Lord

97
Mobile Technology

97
Immunolight ◀

97

What this shows Immunolight holds 97 patents at rank #3,734, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immunolight

By rank, the assignees closest to #3,734 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Immunolight's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Immunolight, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (61 here).

Globalwafers Co., Ltd. 61 PlayNitride Display Co., Ltd. 61 IX Innovation LLC 61 Bendix Commercial Vehicle Systems LLC 61

Similar claim depth

Nearest assignees by average claims per patent (51.1 here).

May Patents Ltd. 47.8 avg Bright Data Ltd. 47.8 avg Outward, Inc. 55.4 avg Sitting MAN, LLC 56.1 avg

Immunolight's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immunolight, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	6.2%
2016	11	11.3%
2017	9	9.3%
2018	10	10.3%
2019	14	14.4%
2020	11	11.3%
2021	8	8.2%
2022	11	11.3%
2023	7	7.2%
2024	9	9.3%
2025partial year	1	1.0%

Which technologies does Immunolight, LLC patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 72

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 64

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 51

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 40

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 40

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 31

Y02W - Climate Change Mitigation Technologies Related TO Wastewater Treatment OR Waste Management 30

Y10T - Technical Subjects Covered BY Former US Classification 29

A23B - Preservation OF Foods, Foodstuffs OR Non-alcoholic BEVERAGES; Chemical Ripening OF Fruit OR Vegetables 28

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 26

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 23

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 22

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 22

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 22

G02B - Optical Elements, Systems OR Apparatus 21

Top 15 of 52 technology areas

Where it ranks

Overall rank by patents

#3,735

of 49,997 tracked assignees

Innovation Score

61.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Immunolight, LLC's patent record in context - here's where to go next.

Immunolight, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 74.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #3,735 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immunolight, LLC against DSP Group Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 61.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.